Table 6.
Correlation between higher mRS score, ICU admission and clinical or imaging manifestations.
ICU admission | P | Onset mRS score (3–6) | P | Last follow-up mRS score (3–6) | P | |
---|---|---|---|---|---|---|
(n = 6) | (n = 11) | (n = 3) | ||||
Age (>50y), n = 12 | 1 | 0.293 | 4 | 0.928 | 1 | 0.941 |
Gender (male), n = 28 | 5 | 0.945 | 9 | 0.955 | 2 | 0.455 |
Hyponatraemia, n = 17 | 1 | 0.072 | 5 | 0.714 | 3 | 0.07 |
Meningitis, n = 25 | 5 | 0.549 | 8 | 0.942 | 3 | 0.276 |
Linear perivascular radial enhancement, n = 14 | 3 | 0.628 | 6 | 0.273 | 3 | 0.03 |
Basal ganglia lesions, n = 15 | 4 | 0.22 | 6 | 0.397 | 1 | 0.694 |
Thalamic lesions, n = 9 | 3 | 0.15 | 4 | 0.366 | 1 | 0.778 |
Brainstem lesions, n = 11 | 4 | 0.048 | 7 | 0.007 | 2 | 0.183 |
Intramedullary lesions, n = 19 | 5 | 0.196 | 9 | 0.064 | 3 | 0.238 |
IVIG therapy, n = 10 | 5 | 0.156 | 2 | 0.138 |
IVIG, intravenous immunoglobulin.